Business
BeyondSpring Appoints Commercial Leader Mark Santos to its Board of Directors
NEW YORK, Nov. 10, 2021 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a clinical stage biopharmaceutical
About this update from Beyondspring, Inc.
[{"type":"text","content":"NEW YORK, Nov. 10, 2021 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a clinical stage biopharmaceutical company focused on the development of innovative cancer therapeutics, today announced the appointment of Mark Santos, RPh, to its Board of Directors, effective immediately. Mr. Santos has over 30 years of executive experience across the healthcare and pharmaceutical industries, currently serving as the Senior Vice President of Pharma Strategy & Contracting at OneOncology. He was President of ION Solutions, the leading GPO in the U.S., from 2011 to 2018. “We’re honored to have industry veteran Mr. Santos join our Board as BeyondSpring is making the transition into an R&D and commercial company. As President of ION Solutions, he was instrumental in developing a multi-layered approach that drove innovative value for ION’s pharmaceutical partners and physician members, and helped transform and optimize the contracting process,” said Dr. Lan Huang, co-founder, CEO and chairwoman of BeyondSpring. “Mr. Santos’ knowledge of industry needs, combined with his exceptional understanding of community practices, brings great value to the planning and launch support for new agents into the oncology market.” Mark Santos, RPh, added, “It is exciting to be joining BeyondSpring’s Board at this critical value inflection point where plinabulin’s clinical data has demonstrated its potential to make a significant impact in the oncology space as both an anti-cancer agent and in CIN prevention. As someone who has worked in oncology for much of my career, I very much look forward to being a part of this important next step in plinabulin’s journey and to seeing it potentially make a difference in the lives of cancer patients globally.” In 2001, Mr. Santos joined the startup phase of what became ION Solutions GPO where under his leadership as President, the GPO grew to a market leadership position. He currently serves as a board member of several other institutions, including Healthy Engage, the American Cancer Society (South Texas Chapter), the NY Cancer Foundation and the Leukemia Texas Foundation (Houston Chapter). He also has provider experience as a chemotherapy compounding pharmacist from his time in private practice. Mr. Santos has a B.S. in pharmacy from the Xavier University of Louisiana Coll...